How does lipitor differ from other statins?

How does Lipitor differ from other statins?

Lipitor contains atorvastatin as its active ingredient. It belongs to a moderate-to-high intensity statin group and commonly achieves LDL reductions of 40-55%. Many patients achieve their targets with 10-40 mg daily doses. [1]

What makes atorvastatin more potent than simvastatin or pravastatin?

Atorvastatin blocks HMG-CoA reductase more persistently because it has a longer half-life of 14 hours. This property allows once-daily dosing and produces larger LDL reductions than older statins at equivalent doses. [1]

Why are companies challenging this patent?

The original atorvastatin patent expired in 2011. Since then, multiple generic manufacturers have challenged secondary patents on specific formulations and crystal forms. Challenges often focus on obviousness and whether new forms could be claimed separately. [2]

How does Lipitor compare with Crestor?

Both atorvastatin and rosuvastatin belong to high-intensity statins. Crestor reaches 45-63% LDL reduction at 5-20 mg doses. Lipitor and Crestor show comparable cardiovascular event reduction in head-to-head studies. At lower doses, Crestor sometimes achieves similar targets with less myalgia. [3]

When does exclusivity expire?

The compound patent expired long ago. Remaining exclusivity now rests on pediatric extensions and formulation patents held by Pfizer. These extensions ended around 2016. No primary exclusivity remains in the U.S. for plain atorvastatin tablets. [2]

What side effects are patients asking about?

Patients report muscle pain, liver enzyme elevations, and rare rhabdomyolysis. Atorvastatin's risk profile matches other statins except for a few reports of higher rates of new-onset diabetes. Reports show no consistent difference in cognitive claims between atorvastatin and other statins. [1]

Can biosimilars enter before patent expiry?

Atorvastatin is a small-molecule chemical entity, not a biological agent. Biosimilars do not apply. Generic versions entered the U.S. market after 2011 when compound and some formulation patents were challenged and invalidated. [2]

Who makes Lipitor?

Pfizer markets the brand-name version. Generic atorvastatin is produced by multiple manufacturers including Teva, Mylan, and Ranbaxy. Pfizer still sells branded Lipitor in some markets where generics remain unavailable. [1]

When will generics dominate?

After 2011, generics quickly took 90% of the U.S. market share. Today, generics chair the supply for most countries. The cost difference between brand and generic reaches 90% savings on daily doses. [2]